Classer les publications sur l'année
-
Ăconomie de la santĂ©
L’Ă©valuation mĂ©dico-Ă©conomique : une place qui reste Ă trouverâŠ
DETOURNAY B
La Lettre du CollĂšge ; 2012;2:5-7
-
Ăconomie de la santĂ©
Insulin therapy for diabetes mellitus: Treatment regimens and associated costs
CHARBONNEL B, PENFORNIS A, VARROUD-VIAL M, KUSNIK-JOINVILLE O, DETOURNAY B
Diabetes Metab ; 2012;38:156-163
-
Pharmaco-Epidémiologie
Feasibility and acceptability of rapid HIV test screening (DEPIVIH) by French family physicians
GAUTHIER R, LIVROZET JM, PREVOTEAU DU CLARY F, TAULERA O, BOUEE S, AUBERT JP, PY AM , PETER JM, MAJERHOLC C, HĂBER SUFFRIN S, COMPAGNON C, WAJSBROTÂ A
Med Mal Infect ; 2012;42:553-560
-
Santé publique
Evaluer les activitĂ©s d’Ă©ducation thĂ©rapeutique : pourquoi ? Pour qui ?
DETOURNAY B
Education Thérapeutique : L'Evaluation ; 2012;8-12
-
Pharmaco-Epidémiologie
ESPERA study : Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice
DE TOFFOL B, DE ZELICOURT M, VESPIGNANI H, FAGNANI F, LAURENDEAU C, LEVY-BACHELOT L, MURAT C, GASALLA T, ARZIMANOGLOU A, VILLANUEVA V
Epilepsy Behav ; 2012;25(2):166-169
-
Pharmaco-Epidémiologie
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe study
SPIELMANN M, LUPORSI E, RAY-COQUARD I, DE BOTTON S, AZRIA D, LASOCKI S, LAFUMA A, MAHI L, DERAY G, BUGAT R
A, MAHI L, DERAY G, BUGAT REur J Cancer ; 2012;48(1):101-107
-
Pharmaco-Epidémiologie
Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient : a prospective, randomised study
DAHAN E, BEN SIMON GJ, LAFUMA A
Eye ; 2012;26(5):703-710
-
Pharmaco-Epidémiologie
Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes
DETOURNAY B, SIMON D, GUILLAUSSEAU PJ, JOLY D, VERGES B, ATTALI C, CLEMENT O, BRIAND Y, DELAITRE O
Diabetes Metab ; 2012;38:102-112
-
Pharmaco-Epidémiologie
An observational study of the initial management of hypothyroidism in France : the ORCHIDEE Study
DELEMER B, AUBERT JP, NYS P, LANDRON F, BOUEE S
Eur J Endocrinol ; 2012;167:817-823
-
Pharmaco-Epidémiologie
A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: The AVANCE study
HALIMI S, AUBERT JP, FONTBONNE A, GUILLAUSSEAU PJ, NACHIT F, BOUEE S, DETOURNAY B
Diabetes Metab ; 2012;38:343-351
-
Pharmaco-Epidémiologie
Traitements antidiabĂ©tiques des patients diabĂ©tiques de type 2 atteints dâune insuffisance rĂ©nale modĂ©rĂ©e ou sĂ©vĂšre suivis en mĂ©decine gĂ©nĂ©rale en France
BOUEE S, GAUDIN AF, AMELINEAU E, BONNET F
Thérapie ; 2013;68(1):19-26
-
Ăconomie de la santĂ©
The association between asthma control, health care costs, and quality of life in France and Spain
DOZ M, CHOUAID C, COM-RUELLE L, CALVO E, BROSA M, ROBERT J, DECUYPERE L, PRIBIL C, HUERTA A, DETOURNAY B
BMC Pulm Med ; 2013;22:13-15
-
Ăconomie de la santĂ©
Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study
VILLANUEVA V, GIRĂN JM, MARTĂN J, HERNĂNDEZ-PASTOR LJ, LAHUERTA J, DOZ M, CUESTA M, LĂVY-BACHELOT L; INVESTIGADORES DEL ESTUDIO ESPERA
Neurologia ; 2013;28(4):195-204
-
Ăconomie de la santĂ©
Le reste à charge des patients diabétiques en France en 2007
DETOURNAY B, ROBERT J, GADENNE S
BEH ; 2013;37-38:471-476
-
Ăconomie de la santĂ©
LâĂ©valuation mĂ©dico-Ă©conomique des produits de santĂ© dans le contexte de la loi de financement de la SĂ©curitĂ© sociale pour 2012
DERVAUX B, BASEILHAC E, FAGON JY, AMEYE V, ANGOT P, AUDRY A, BECQUEMONT L, BOREL T,CAZENEUVE B, COURTOIS J, DETOURNAY B, FAVRE P, et al
Thérapie ; 2013;68(4):253-257